ScholarIQanswers from OpenAlex & ORCID
Cesare Gridelli
ResearcherPublications, citations & collaboration network
Cesare Gridelli is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Cesare Gridelli have?
ScholarIQindexed works
Cesare Gridelli has 546 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Cesare Gridelli have?
ScholarIQcitation count
Cesare Gridelli has 19,624 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Cesare Gridelli?
ScholarIQh-index
Cesare Gridelli has an h-index of 68 in OpenAlex.
What is the i10-index of Cesare Gridelli?
ScholarIQi10-index
Cesare Gridelli has an i10-index of 285 in OpenAlex.
What is the ORCID of Cesare Gridelli?
ScholarIQorcid
The ORCID for Cesare Gridelli is on the source record.
What is the OpenAlex record for Cesare Gridelli?
ScholarIQopenalex
The OpenAlex for Cesare Gridelli is on the source record.
What are the most-cited papers on Cesare Gridelli?
ScholarIQmost cited works
Non-small-cell lung cancer
Cesare Gridelli, Antônio Rossi, David P. Carbone, Juliana Guarize, Niki Karachaliou, Tony Mok, Francesco Petrella, Lorenzo Spaggiari, Rafael Rosell
Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer
D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn, James Chih‐Hsin Yang, Ji‐Youn Han, Jong Seok Lee, Maximilian J. Hochmair, Jacky Yu-Chung Li, Gee‐Chen Chang, Ki Hyeong Lee, Cesare Gridelli, Angelo Delmonte, Rosario García Campelo, Dong‐Wan Kim, Alessandra Bearz, Frank Griesinger, Alessandro Morabito, Enriqueta Felip, Raffaele Califano, Sharmistha Ghosh, Alexander I. Spira, Scott Gettinger, Marcello Tiseo, Neeraj Gupta, J. Haney, David Kerstein, Sanjay Popat
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
Alice T. Shaw, Tae Min Kim, Lucio Crinò, Cesare Gridelli, Katsuyuki Kiura, Geoffrey Liu, Silvia Novello, Alessandra Bearz, Oliver Gautschi, Tony Mok, Makoto Nishio, Giorgio V. Scagliotti, David R. Spigel, Stéphanie Deudon, Cheng Zheng, Serafino Pantano, Patrick Urban, Cristian Massacesi, Kalyanee Viraswami-Appanna, Enriqueta Felip
Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
Antônio Rossi, Massimo Di Maïo, Paolo Chiodini, Robin Rudd, Hiroaki Okamoto, Dimosthenis Skarlos, Martin Früh, Wendi Qian, Tomohide Tamura, E. Samantas, Taro Shibata, Francesco Perrone, Ciro Gallo, Cesare Gridelli, Olga Martelli, Siow Ming Lee
Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study
Paolo Maione, Francesco Perrone, Ciro Gallo, Luigi Manzione, Francovito Piantedosi, Santi Barbera, S. Cigolari, Francesco Rosetti, Elena Piazza, Sergio Robbiati, Oscar Bertetto, Silvia Novello, Maria Rita Migliorino, Adolfo Favaretto, Mario Spatafora, Francesco Ferraù, Luciano Frontini, Alessandra Bearz, Lazzaro Repetto, Cesare Gridelli